Showing results (751-760 of 972) with videos related to

Sort By:
Pageof 98
Gastroenterology|July 23, 2018
Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisBenjamin Wildman-Tobriner, Michael M Middleton, Cynthia A Moylan, et al.
European Journal of Nutrition|October 14, 2009
Alcohol consumption and the risk of coronary heart disease in postmenopausal women with diabetes: Women's Health Initiative Observational StudySwapnil N Rajpathak, Mathew S Freiberg, Cuiling Wang, et al.
Cell Death & Disease|March 8, 2019
Identification of a novel class of RIP1/RIP3 dual inhibitors that impede cell death and inflammation in mouse abdominal aortic aneurysm modelsTing Zhou, Qiwei Wang, Noel Phan, et al.
Molecular Phylogenetics and Evolution|June 10, 2004
Mitochondrial evidence for the origin of hamadryas baboonsDerek E Wildman, Thore J Bergman, Abdulwali al-Aghbari, et al.
The Journal of Antibiotics|June 29, 2005
A novel aspochalasin with HIV-1 integrase inhibitory activity from Aspergillus flavipesSimone Rochfort, Joanne Ford, Simon Ovenden, et al.
Arthritis and Rheumatism|March 4, 2008
Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosusTrina Thompson, Kim Sutton-Tyrrell, Rachel P Wildman, et al.
Journal of the American Society of Nephrology : JASN|July 8, 2005
Regulatory interdependence of cloned epithelial Na+ channels and P2X receptorsScott S Wildman, Joanne Marks, Linda J Churchill, et al.
Journal of Healthcare Leadership|January 23, 2018
Design, implementation, and demographic differences of HEAL: a self-report health care leadership instrumentKelly R Murphy, John E McManigle, Benjamin M Wildman-Tobriner, et al.
Abdominal Radiology (New York)|September 20, 2020
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?Islam H Zaki, Erin Shropshire, Shuaiqi Zhang, et al.
Arthritis Research & Therapy|August 19, 2015
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trialJessica K Gordon, Viktor Martyanov, Cynthia Magro, et al.
Pageof 98